Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.82−0.71 (-20.00%)
Close on Oct 19, 2026Market cap $2.28MP/E –Yield –
Jaguar Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Jaguar Health's free cash flow for the twelve months ending Dec 31, 2024 was -$29.40M. For fiscal 2024 it was -$29.40M. The highest annual figure on record is -$5.41M in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$29.40M | – |
| FY2022 | Dec 31, 2022 | -$33.18M | – |
| FY2021 | Dec 31, 2021 | -$34.98M | – |
| FY2020 | Dec 31, 2020 | -$15.29M | – |
| FY2018 | Dec 31, 2018 | -$22.74M | – |
| FY2016 | Dec 31, 2016 | -$14.52M | – |
| FY2015 | Dec 31, 2015 | -$14.34M | – |
| FY2014 | Dec 31, 2014 | -$5.41M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$7.83M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.34M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.79M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.95M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.42M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.53M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.00M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.30M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.90M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.81M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.73M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.39M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.79M | – |
See a number that looks wrong?